Alzamend Neuro (ALZN) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Maxim Group Maintains Alzamend Neuro(ALZN.US) With Hold Rating
Moomoo News16:31 ET · Ratings
Alzamend Neuro (ALZN) Gets a Hold From Maxim Group
TipRanks15:45 ET · Ratings
Express News | Alzamend Neuro Announces Initiation Date of First Phase II Clinical Trial of Al001 to Take Place at Massachusetts General Hospital
ReutersFeb 25 08:00 ET
Alzamend Neuro Announces Initiation Date of First Phase II Clinical Trial of AL001 to Take Place at Massachusetts General Hospital
Alzamend NeuroFeb 25 08:00 ET
EXCLUSIVE: Alzamend Neuro To Start First Phase 2 Study For Lead Candidate In 2025
BenzingaFeb 25 07:30 ET
Express News | EXCLUSIVE: Alzamend Neuro Tells Benzinga Co. Plans To Initiate The First Of Five Highly Anticipated Phase II Clinical Studies Of AL001, With The Study, In Healthy Human Subjects, Expected To Commence In Q2 2025
BenzingaFeb 25 07:30 ET

Comments

Teddy123

Feb 25 07:11

Alzamend Neuro Announces Initiation Date of First Phase II Clinical Trial of AL001 to take Place at Massachusetts General Hospital

$Alzamend Neuro (ALZN.US)$
Can Alzamend's New Lithium Formulation Eliminate Monitoring Requirements? Phase II Trial Set for 2025

1

Jaguar8

Feb 25 06:31

NEWS

$Alzamend Neuro (ALZN.US)$
EXCLUSIVE: Alzamend Neuro To Start First Phase 2 Study For Lead Candidate In 2025
Benzinga· 1 min ago
Alzamend Neuro(ALZN.US)
On Tuesday, Alzamend Neuro, Inc. (NASDAQ:ALZN) announced its plans to initiate the first of five phase 2 clinical studies of AL001. The first study, in healthy human subjects, is expected to commence in the second quarter of 2025.
The study follows the development of a novel head coil by Tesla Dynamic Coils BV, a key component of the clinical...

Hyot_yeah

Feb 19 08:33

$Alzamend Neuro (ALZN.US)$ Trash

Trytosaveabit

Feb 19 06:33

update

$Alzamend Neuro (ALZN.US)$ EXCLUSIVE: Alzamend Tells Benzinga 'Head-to-head Studies of AL001 Versus a Marketed Lithium Carbonate Product Will Be Conducted for Comparisons of Lithium Blood and Brain/brain-structure Pharmacokinetics in Healthy, Alzheimer's Disease, BD, MDD, and PTSD'
Benzinga· 1 min ago
On Wednesday, Alzamend Neuro, Inc. (NASDAQ:ALZN) announced it had completed the head coil by Tesla Dynamic Coils BV.
The development of the head coil was necessary to facilitate Alzamend's fiv...

1

Jaguar8

Dec 12, 2024 07:05

NEWS ER

$Alzamend Neuro (ALZN.US)$
Alzamend Neuro Reports Second Quarter 2025 Financial Results and Provides Update on Clinical Programs
Thursday, 12th December at 8:00 am
• During the six months ended October 31, 2024, net cash provided by financing activities was $8.3 million
• Stockholder equity of $3.8 million at October 31, 2024, including $4.1 million of cash
• Strengthened balance sheet in preparation for five clinical trials to be initiated in 2025
Alzamend Neuro, Inc. (NASDAQ: ALZN) ("...

1

ALZN Alzamend Neuro

Trade Overview

Capital Trend

News

Comments

Trending Stocks